ACMG sets new lifelong guidelines for managing phenylalanine hydroxylase deficiency Post author: Post published: December 4, 2024 Post category:uncategorized Updated evidence-based clinical guidelines for phenylalanine hydroxylase deficiency diagnosis and management. You Might Also Like New drug strategy reverses resistance to immunotherapy in pancreatic cancer November 14, 2024 Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season September 28, 2025 WHO lists first molecular diagnostic test for Bundibugyo virus July 3, 2026
Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season September 28, 2025